Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting β agonist treatment in a multiethnic asthma population: a genetic study

Israel, 2004, Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial, Lancet, 364, 1505, 10.1016/S0140-6736(04)17273-5 Israel, 2000, The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma, Am J Respir Crit Care Med, 162, 75, 10.1164/ajrccm.162.1.9907092 Bleecker, 2010, Beta2-receptor polymorphisms in patients receiving salmeterol with or without fluticasone propionate, Am J Respir Crit Care Med, 181, 676, 10.1164/200809-1511OC Bleecker, 2007, Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies, Lancet, 370, 2118, 10.1016/S0140-6736(07)61906-0 Wechsler, 2009, Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial, Lancet, 374, 1754, 10.1016/S0140-6736(09)61492-6 Drazen, 1996, Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. Asthma Clinical Research Network, N Engl J Med, 335, 841, 10.1056/NEJM199609193351202 Crane, 1989, Prescribed fenoterol and death from asthma in New Zealand, 1981–83: case-control study, Lancet, 1, 917, 10.1016/S0140-6736(89)92505-1 Pearce, 1997, Fenoterol, asthma deaths, and asthma severity, Chest, 112, 1148, 10.1378/chest.112.4.1148-b Castle, 1993, Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment, BMJ, 306, 1034, 10.1136/bmj.306.6884.1034 Nelson, 2006, The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol, Chest, 129, 15, 10.1378/chest.129.1.15 Chowdhury, 2011, Assessing the safety of adding LABAs to inhaled corticosteroids for treating asthma, N Engl J Med, 364, 2473, 10.1056/NEJMp1104375 Suissa, 2013, US Food and Drug Administration-mandated trials of long-acting beta-agonists safety in asthma: will we know the answer?, Chest, 143, 1208, 10.1378/chest.12-2881 Drysdale, 2000, Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness, Proc Natl Acad Sci USA, 97, 10483, 10.1073/pnas.97.19.10483 Hawkins, 2006, Sequence, haplotype, and association analysis of ADRbeta2 in a multiethnic asthma case-control study, Am J Respir Crit Care Med, 174, 1101, 10.1164/rccm.200509-1405OC Lester, 2001, Ethnic differences in asthma and associated phenotypes: collaborative study on the genetics of asthma, J Allergy Clin Immunol, 108, 357, 10.1067/mai.2001.117796 Moore, 2010, Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program, Am J Respir Crit Care Med, 181, 315, 10.1164/rccm.200906-0896OC Wenzel, 2009, A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma, Am J Respir Crit Care Med, 179, 549, 10.1164/rccm.200809-1512OC Haselkorn, 2009, J Allergy Clin Immunol, 124, 895, 10.1016/j.jaci.2009.07.035 Bergmann, 2004, Agreement of self-reported medical history: comparison of an in-person interview with a self-administered questionnaire, Eur J Epidemiol, 19, 411, 10.1023/B:EJEP.0000027350.85974.47 2007, Expert panel report 3 (EPR-3): guidelines for the diagnosis and management of asthma—summary report 2007, J Allergy Clin Immunol, 120, S94 Adzhubei, 2010, A method and server for predicting damaging missense mutations, Nat Methods, 7, 248, 10.1038/nmeth0410-248 Heinemeyer, 1998, Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL, Nucleic Acids Res, 26, 362, 10.1093/nar/26.1.362 Ng, 2001, Predicting deleterious amino acid substitutions, Genome Res, 11, 863, 10.1101/gr.176601 Wu, 2011, Rare-variant association testing for sequencing data with the sequence kernel association test, Am J Hum Genet, 89, 82, 10.1016/j.ajhg.2011.05.029 Yuan, 2006, FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization, Nucleic Acids Res, 34, W635, 10.1093/nar/gkl236 Morris, 2010, An evaluation of statistical approaches to rare variant analysis in genetic association studies, Genet Epidemiol, 34, 188, 10.1002/gepi.20450 Hunter, 2005, Gene-environment interactions in human diseases, Nat Rev Genet, 6, 287, 10.1038/nrg1578 Morris, 2011, Transethnic meta-analysis of genomewide association studies, Genet Epidemiol, 35, 809, 10.1002/gepi.20630 Lee, 2013, General framework for meta-analysis of rare variants in sequencing association studies, Am J Hum Genet, 93, 42, 10.1016/j.ajhg.2013.05.010 Alexander, 2009, Fast model-based estimation of ancestry in unrelated individuals, Genome Res, 19, 1655, 10.1101/gr.094052.109 Purcell, 2007, PLINK: a tool set for whole-genome association and population-based linkage analyses, Am J Hum Genet, 81, 559, 10.1086/519795 Hall, 2006, Beta2-adrenoceptor polymorphisms and asthma from childhood to middle age in the British 1958 birth cohort: a genetic association study, Lancet, 368, 771, 10.1016/S0140-6736(06)69287-8 Thomsen, 2012, Beta2-adrenergic receptor polymorphisms, asthma and COPD: two large population-based studies, Eur Respir J, 39, 558, 10.1183/09031936.00023511 Weir, 1998, Beta2-Adrenergic receptor haplotypes in mild, moderate and fatal/near fatal asthma, Am J Respir Crit Care Med, 158, 787, 10.1164/ajrccm.158.3.9801035 Wechsler, 2011, Impact of race on asthma treatment failures in the asthma clinical research network, Am J Respir Crit Care Med, 184, 1247, 10.1164/rccm.201103-0514OC Ma, 2013, A novel channelopathy in pulmonary arterial hypertension, N Engl J Med, 369, 351, 10.1056/NEJMoa1211097 Walsh, 2007, Ten genes for inherited breast cancer, Cancer Cell, 11, 103, 10.1016/j.ccr.2007.01.010 Green, 1993, A polymorphism of the human beta 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor, J Biol Chem, 268, 23116, 10.1016/S0021-9258(19)49434-9 Green, 2001, The Ile164 beta(2)-adrenoceptor polymorphism alters salmeterol exosite binding and conventional agonist coupling to G(s), Eur J Pharmacol, 421, 141, 10.1016/S0014-2999(01)01049-4 Agarwal, 2000, Beta-adrenergic modulation of human type-1/type-2 cytokine balance, J Allergy Clin Immunol, 105, 91, 10.1016/S0091-6749(00)90183-0 Lazarus, 2001, Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial, JAMA, 285, 2583, 10.1001/jama.285.20.2583 Panina-Bordignon, 1997, Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12, J Clin Invest, 100, 1513, 10.1172/JCI119674 Barbato, 2007, Thr164Ile polymorphism of beta2-adrenergic receptor negatively modulates cardiac contractility: implications for prognosis in patients with idiopathic dilated cardiomyopathy, Heart, 93, 856, 10.1136/hrt.2006.091959 Brodde, 2001, Blunted cardiac responses to receptor activation in subjects with Thr164Ile beta(2)-adrenoceptors, Circulation, 103, 1048, 10.1161/01.CIR.103.8.1048 Liggett, 1998, The Ile164 beta2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure, J Clin Invest, 102, 1534, 10.1172/JCI4059 Emorine, 1987, Structure of the gene for human beta 2-adrenergic receptor: expression and promoter characterization, Proc Natl Acad Sci USA, 84, 6995, 10.1073/pnas.84.20.6995 Meyers, 2008, Pharmacogenetic identification of increased responsiveness in severe asthma with anti-TNF (golimumab) therapy, J Allergy Clin Immunol, 121, S798, 10.1016/j.jaci.2008.01.065